» Articles » PMID: 30513307

Bioassay of Saliva Proteins: The Best Alternative for Conventional Methods in Non-invasive Diagnosis of Cancer

Overview
Publisher Elsevier
Date 2018 Dec 5
PMID 30513307
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Non-invasive diagnosis of cancer is often the key to effective treatment and patient survival. Saliva as a multi-constituent oral fluid comprises various disease signaling biomarkers, holds great potential for early-stage cancer diagnostics with cost-effective and easy collection, storage, transport and processing. Therefore, detection of biomarkers and proteins in the saliva samples is highly demand. The current review was performed using reliable internet database (mainly PubMed) to provide an overview of the most recent developments on non-invasive diagnosis of cancers in saliva and highlights main challenges and future prospects in sensing of the salivary biomarkers. The conventional detection methods of cancer biomarkers in saliva is discussed in the paper, however, the main focus is on non-invasive diagnosis of cancers in saliva using immunosensing (electrochemical, optical, piezoelectric), DNA based sensors, aptasensors and peptide based bio-assays The reviewed literature revealed that non-invasive cancer detection methods using the mentioned biosensors and without any processing of saliva sample offers a quick, sensitive, specific and cost effective analytical tool. Besides, salivary based detection methods can be used for simultaneous detection of panels of disease specific biomarkers in a real time manner or as home testing kits in near future.

Citing Articles

An iRGD-conjugated photothermal therapy-responsive gold nanoparticle system carrying siCDK7 induces necroptosis and immunotherapeutic responses in lung adenocarcinoma.

Cai R, Wang M, Liu M, Zhu X, Feng L, Yu Z Bioeng Transl Med. 2023; 8(4):e10430.

PMID: 37476070 PMC: 10354770. DOI: 10.1002/btm2.10430.


Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation.

Dongiovanni P, Meroni M, Casati S, Goldoni R, Thomaz D, Kehr N Int J Oral Sci. 2023; 15(1):27.

PMID: 37386003 PMC: 10310701. DOI: 10.1038/s41368-023-00231-6.


Potential Diagnostic Value of Salivary Tumor Markers in Breast, Lung and Ovarian Cancer: A Preliminary Study.

Belskaya L, Sarf E, Loginova A, Vyushkov D, Choi E Curr Issues Mol Biol. 2023; 45(6):5084-5098.

PMID: 37367072 PMC: 10297235. DOI: 10.3390/cimb45060323.


Non-Invasive Lung Cancer Diagnostics through Metabolites in Exhaled Breath: Influence of the Disease Variability and Comorbidities.

Temerdashev A, Gashimova E, Porkhanov V, Polyakov I, Perunov D, Dmitrieva E Metabolites. 2023; 13(2).

PMID: 36837822 PMC: 9960124. DOI: 10.3390/metabo13020203.


High sensitivity CIP2A detection for oral cancer using a rapid transistor-based biosensor module.

Xian M, Stephany J, Chiu C, Chiang C, Ren F, Tsai C J Vac Sci Technol B Nanotechnol Microelectron. 2022; 41(1):013201.

PMID: 36531804 PMC: 9750712. DOI: 10.1116/6.0002175.